Patrick Colin

Bringing more than 33 years of experience in various corporate environments, encompassing large multinational firms, growing biopharmaceutical companies and biotechs/start-ups, Patrick is an expert in preclinical and clinical drug development (phases 1 to 4). He managed multiple clinical programs in North America and Europe, and has also experience in conducting clinical trials in developing countries (Latin America).